Richtig, Erika
Funding for this research was provided by:
Medical University of Graz
Article History
Received: 29 January 2020
Accepted: 10 March 2020
First Online: 15 April 2020
Conflict of interest
: E. Richtig declares speakers fees, congress supports, and honoraria for advisory boards from Almirall, Amgen, Astra Zeneca, BMS, GSK, MSD, Merck, Novartis, Pierre Fabre, Roche, and Sanofi.